Cell and Gene Therapy Bioassay Services Market | Size, Share and Scope Analysis to 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Cell and Gene Therapy Bioassay Services Market (Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological, Cardiovascular, Infectious, Autoimmune, Rare/Genetic, Metabolic, Neurological, Blood, Ophthalmic Disorders, and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical, Clinical)- Market Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

According to the latest research by InsightAce Analytic, the global cell and gene therapy bioassay services market is valued at US$ 1.63 Billion in 2021, and it is expected to reach US$ 5.64 Billion by 2030 with a CAGR of 15.0% during a forecast period of 2022-2030.

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1208

Cell and gene therapies involve extracting and modifying the patient's or donor's protein, cells, or genetic material to provide a highly targeted or individualised treatment. These therapies provide longer-lasting benefits than conventional remedies for complex and rare diseases. Over the years, the demand for numerous contract research organisations that provide bioassay services for cell and gene therapies has increased.

Numerous factors, including the rising demand for sophisticated therapy treatments, the rising incidence of cancer and other chronic diseases, and the advancements in genomics technology methods, are primarily responsible for the market's expansion. Increasing demand for personalised therapies and increasing government funding for the R&D of innovative cell & gene therapies are expected to further boost demand for bioassay services over the forecast period. In response to the rising demand for cost-effective and effective cell & gene therapies, contract research organisations (CROs) have expanded their bioassay services, thereby creating opportunities for market growth in the near future. Various contract research organisations professing to offer bioassay services for cell and gene therapies have emerged in response to the growing demand for outsourcing bioanalytical services. In the coming years, the high cost of bioassay services may hinder the expansion of the global cell and gene therapy bioassay services market.

Geographically, North America is anticipated to hold the largest market share during the forecast period, owing to the increasing launch of cell and gene therapy products and the rising R&D activities of biopharma companies to develop cell and gene therapies.

Request for ToC: https://www.insightaceanalytic.com/report/global-cell-and-gene-therapy-bioassay-services-market/1208

Major market players operating in the cell and gene therapy bioassay services market include AnaBioTec (Belgium), CCRM (Canada), Nexelis (Canada), Lonza (Switzerland), PPD Laboratories (North Carolina), Intertek Pharmaceutical Services (UK), Pacific BioLabs (US), WuXi Advanced Therapies (US), Porton Biopharma Ltd (UK), Avomeen (US), Charles River Laboratories (US), BioAgilytix Labs (US), Absorption Systems (US), Catalent, Inc (US), Svar Life Science AB (Sweden) among others.

Some significant developments in the market:
• In Dec 2021, Mediphage Bioceuticals, Inc. has been acquired by CCRM Enterprises Inc., the company's venture capital arm. CCRM Enterprises' investment will be used to fund the technology's development and continued operations, as well as access to CCRM's scientific and industrial experience. Mediphage is focusing on a non-viral gene therapy platform that will pave the way for personalized genetic treatment that is both safe and effective, while also addressing many of the drawbacks of current viral vector-based gene therapy technologies.
• In April 2021, AavantiBio (US), a gene therapy company, and Catalent (US), the provider of drugs, cell & gene therapies, partnered to support the development and manufacturing of AavantiBio's gene therapies.
• In November 2021, WuXi Advanced Therapies (US) opened a new cell and gene therapy testing facility with 140,000 square feet of laboratory space. This facility will further enhance the company's contract testing, development, and manufacturing organization (CTDMO) business model by tripling the company's previous testing capacity, meeting the increasing needs of customers in the cell and gene therapy industry.
• In April 2021, PPD, Inc., a global contract research organization ( CRO ), is expanding its Athlone, Ireland, GMP laboratory, increasing the size of its current facility and adding cell and gene therapy testing to the operation's portfolio of services.The expansion enhances PPD's ability to deliver global scientific and technical expertise to meet growing customer demand in Europe, the Middle East and Africa, and the Asia-Pacific region
• In Jan 2021, Nexelis has signed an asset purchase agreement with GSK to acquire its GCLP-certified clinical bioanalytical laboratory located in Marburg, Germany.Nexelis intends to quickly expand the Marburg site, initiating collaborations with other vaccine development companies as well as with the company's other North American and European sites.

Obtain Full Report Details @ https://www.insightaceanalytic.com/request-sample/1208

Market Segments
Global Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Type of Therapy, 2019-2030 (Value US$ Mn)
• Gene Therapy
• Cell Therapy

Global Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Therapeutic Area, 2019-2030 (Value US$ Mn)
• Oncological
• Cardiovascular
• Autoimmune
• Rare / Genetic
• Neurological
• Metabolic
• Blood
• Ophthalmic Disorders
• Infectious
• Other Therapeutic Areas

Global Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Scale of Operation, 2019-2030 (Value US$ Mn)
• Preclinical
• Clinical
• Discovery

Global Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Region, 2019-2030 (Value US$ Mn)
• Europe
• North America
• Asia Pacific
• Middle East & Africa
• Latin America

North America Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Country, 2019-2030 (Value US$ Mn)
• Canada
• U.S.

Europe Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Country, 2019-2030 (Value US$ Mn)
• Italy
• Germany
• Spain
• France
• Rest of Europe

Asia Pacific Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Country, 2019-2030 (Value US$ Mn)
• India
• Japan
• South Korea
• China
• Australia & New Zealand

Latin America Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Country, 2019-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Cell and Gene Therapy Bioassay Services Market (Revenue Forecast and Industry Analysis), by Country, 2019-2030 (Value US$ Mn)
• South Africa
• GCC Countries
• Rest of Middle East & Africa

Why should buy this market research report:
 To receive a key insights of the prospects for the global cell and gene therapy bioassay services market
 To receive an market overview and future trends of the cell and gene therapy bioassay services market
 To analyze the cell and gene therapy bioassay services market drivers and challenges
 To get information on the cell and gene therapy bioassay services market size value (US$ Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the cell and gene therapy bioassay services market industry

Get More Information @ https://www.insightaceanalytic.com/report/global-cell-and-gene-therapy-bioassay-services-market/1208

InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: https://www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Follow Us @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/

Subscribe Our Exclusive Newsletters @ https://www.linkedin.com/newsletters/latest-market-research-reports-6929319878155739136/

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.